Trilogy Capital Inc. Medifast Inc Transaction History

Trilogy Capital Inc.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Oct 16, 2023	SELL	$74.85 - $107.06 $23,652 - $33,830	-316 Reduced 9.59%	2,978 $222,000
Q2 2023 Jul 24, 2023	BUY	$78.7 - $102.49 $39,428 - $51,347	501 Added 17.94%	3,294 $303,000
Q1 2023 Apr 17, 2023	BUY	$97.09 - $130.31 $100,488 - $134,870	1,035 Added 58.87%	2,793 $289,000
Q4 2022 Feb 09, 2023	BUY	$103.38 - $126.05 $181,742 - $221,595	1,758 New	1,758 $202,000

180

10.4M

554K

545K

Ticker MED
Exchange NYSE
Sector Consumer Cyclical
Industry Personal Services
Shares Outstandng 11,017,900
Market Cap $206M
Description
Medifast, Inc., through its subsidiaries, manufactures and distributes weight loss, weight management, healthy living products, and other consumable health and nutritional products in the United States and the Asia-Pacific. The company offers bars, bites, pretzels, puffs, cereal crunch, drinks, hearty choices, oatmeal, pancakes, pudding, soft se...

Get notified when there are updates to the investment portfolio of Trilogy Capital Inc., based on Form 13F filings with the SEC.

Stay updated on Trilogy Capital Inc. with notifications on news.